Caredx Inc (CDNA) - News Archive

Revolutionizing Transplant Care: CareDx Unveils Groundbreaking Innovations and Research at ASN Kidney Week 2025 and World Transplant CongressIn the rapidly advancing field of transplant medicine, CareDx, Inc. (Nasdaq: C...

Revolutionizing Transplant Medicine: CareDx s Breakthrough Innovations at the Forefront In the rapidly evolving world of precision medicine, CareDx, Inc. stands as a beacon of transformative potential and groundbreaking...

Utilizing Precision Medicine: CareDx s Innovative Studies Transforming Transplant OutcomesIn the evolving landscape of transplant medicine, precision tools are steadily emerging as pivotal in improving patient care and...

In the realm of transplant diagnostics, CareDx, Inc., headquartered in Brisbane, California, has emerged as a trailblazer, showcasing its commitment to precision medicine with impressive results at the 2025 World Transp...

In a significant advancement for transplant medicine, CareDx, Inc. (Nasdaq: CDNA), has unveiled promising findings regarding its AlloSeq cfDNA technology, demonstrating its high precision in detecting organ transplant r...

CareDx Teams Up with TC BioPharm to Enhance Cell Therapy Pharmacokinetics in ACHIEVE Clinical Trial: A Leap Forward in Allogeneic Transplant Monitoring and Risk Prediction In a significant move set against the backdrop...

In a significant development for the biotechnology sector, CareDx, Inc. (Nasdaq: CDNA), a prominent player in precision medicine dedicated to transplant health, has announced the conclusion of a Department of Justice (D...

CareDx, Inc. Experiences Significant Growth After Upgraded Forecasts: A Look Into Q2 Performance and Market ReactionsIn a series of optimistic updates surrounding its financial performance, CareDx, Inc. (NASDAQ: CDNA) h...

Breakthrough Study Validates CareDx s AI-Enabled Risk Prediction Model and Detects Subclinical Rejection in Stable PatientsIn a significant development for the field of transplant medicine, CareDx, Inc. has announced th...

Brisbane, California - CareDx, Inc. (Nasdaq: CDNA), a pioneering precision medicine company dedicated to improving the lives of transplant patients and caregivers, has generated buzz at the 2024 American Transplant Cong...

In a groundbreaking study published in The Journal of Heart and Lung Transplantation, CareDx, Inc., a leading precision medicine company dedicated to transforming the lives of transplant patients, has unveiled a major b...

BRISBANE, Calif. CareDx, Inc. (Nasdaq: CDNA), a pioneering precision medicine company dedicated to the development and commercialization of high-value healthcare solutions for transplant patients and caregivers, has ann...